BHAGCHEM.NSBHAGCHEM.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +38.13% | +10.37% | +11.12% | +35.06% | +10.94% |
| Gross Profit Growth | +6.05% | +16.44% | +43.48% | +19.89% | +19.61% |
| EBITDA Growth | +28.47% | -43.70% | -32.49% | +19.76% | +22.85% |
| Operating Income Growth | -0.65% | -77.90% | -41.42% | +76.26% | +58.38% |
| Net Income Growth | +8.35% | -112.25% | -30.27% | +1.17% | +28.43% |
| EPS Growth | -9.38% | -110.54% | -36.00% | -2.33% | +24.14% |
| EPS Diluted Growth | +3.57% | -110.54% | -34.69% | +0.00% | +24.14% |
| Weighted Average Shares Growth | +19.59% | +0.11% | +8.95% | +3.57% | +3.04% |
| Weighted Average Shares Diluted Growth | +4.66% | +16.82% | +6.77% | +1.17% | +3.04% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +61.88% | +0.00% | +34.08% | +0.00% |
| Inventory Growth | +0.00% | +16.34% | +0.00% | -9.04% | +0.00% |
| Asset Growth | +0.00% | +61.99% | +0.00% | +24.74% | +0.00% |
| Book Value per Share Growth | +64.87% | +64.72% | +51.35% | +6.20% | +0.00% |
| Debt Growth | +0.00% | +44.25% | +0.00% | +115.40% | +0.00% |
| R&D Expense Growth | +0.00% | +20.37% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.00% | +137.90% | -100.00% | +0.00% | +0.00% |